468 related articles for article (PubMed ID: 28750141)
21. Ambulatory end-stage liver disease in Ghana; patient profile and utility of alpha fetoprotein and aspartate aminotransferase: platelet ratio index.
Nartey YA; Awuku YA; Agyei-Nkansah A; Duah A; Bampoh SA; Ayawin J; Asibey SO; Björkström NK; Ye W; Afihene MY; Roberts LR; Plymoth A
BMC Gastroenterol; 2020 Dec; 20(1):428. PubMed ID: 33357229
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans.
El-Serag HB; Kramer J; Duan Z; Kanwal F
J Viral Hepat; 2016 Sep; 23(9):687-96. PubMed ID: 27040447
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.
Chen TH; Chen CJ; Yen MF; Lu SN; Sun CA; Huang GT; Yang PM; Lee HS; Duffy SW
Int J Cancer; 2002 Mar; 98(2):257-61. PubMed ID: 11857416
[TBL] [Abstract][Full Text] [Related]
24. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
25. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.
Sterling RK; Jeffers L; Gordon F; Sherman M; Venook AP; Reddy KR; Satomura S; Schwartz ME
Am J Gastroenterol; 2007 Oct; 102(10):2196-205. PubMed ID: 17617202
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.
Kubicka S; Rudolph KL; Hanke M; Tietze MK; Tillmann HL; Trautwein C; Manns M
Liver; 2000 Jul; 20(4):312-8. PubMed ID: 10959810
[TBL] [Abstract][Full Text] [Related]
27. Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era.
Waziry R; Gomaa A; Waked I; Dore GJ
Arab J Gastroenterol; 2018 Mar; 19(1):26-32. PubMed ID: 29506913
[TBL] [Abstract][Full Text] [Related]
28. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
29. Hepatocellular carcinoma in southern Germany: epidemiological and clinicopathological characteristics and risk factors.
Hellerbrand C; Hartmann A; Richter G; Knöll A; Wiest R; Schölmerich J; Lock G
Dig Dis; 2001; 19(4):345-51. PubMed ID: 11935095
[TBL] [Abstract][Full Text] [Related]
30. Post-treatment levels of α-fetoprotein predict incidence of hepatocellular carcinoma after interferon therapy.
Oze T; Hiramatsu N; Yakushijin T; Miyazaki M; Yamada A; Oshita M; Hagiwara H; Mita E; Ito T; Fukui H; Inui Y; Hijioka T; Inada M; Katayama K; Tamura S; Yoshihara H; Inoue A; Imai Y; Hayashi E; Kato M; Miyagi T; Yoshida Y; Tatsumi T; Kasahara A; Hamasaki T; Hayashi N; Takehara T;
Clin Gastroenterol Hepatol; 2014 Jul; 12(7):1186-95. PubMed ID: 24321207
[TBL] [Abstract][Full Text] [Related]
31. Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis.
Jepsen P; Kraglund F; West J; Villadsen GE; Sørensen HT; Vilstrup H
J Hepatol; 2020 Nov; 73(5):1030-1036. PubMed ID: 32512015
[TBL] [Abstract][Full Text] [Related]
32. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis.
Izzo F; Cremona F; Ruffolo F; Palaia R; Parisi V; Curley SA
Ann Surg; 1998 Apr; 227(4):513-8. PubMed ID: 9563539
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma in Danish patients: a single Copenhagen center experience.
Stefansdottir J; Christensen E; Schiødt FV
Scand J Gastroenterol; 2017; 52(6-7):768-772. PubMed ID: 28355956
[TBL] [Abstract][Full Text] [Related]
34. Surveillance factors change outcomes in patients with hepatocellular carcinoma due to chronic hepatitis C virus infection in New Zealand.
Schauer C; van Rijnsoever M; Gane E
J Viral Hepat; 2019 Dec; 26(12):1372-1376. PubMed ID: 31323163
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients.
Burnett NP; Dunki-Jacobs EM; Callender GG; Anderson RJ; Scoggins CR; McMasters KM; Martin RC
Am Surg; 2013 Jul; 79(7):716-22. PubMed ID: 23816006
[TBL] [Abstract][Full Text] [Related]
36. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
[TBL] [Abstract][Full Text] [Related]
37. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM
PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823
[TBL] [Abstract][Full Text] [Related]
38. A prospective multicenter study of hepatocellular carcinoma in italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers.
Tradati F; Colombo M; Mannucci PM; Rumi MG; De Fazio C; Gamba G; Ciavarella N; Rocino A; Morfini M; Scaraggi A; Taioli E
Blood; 1998 Feb; 91(4):1173-7. PubMed ID: 9454746
[TBL] [Abstract][Full Text] [Related]
39. Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study.
Ahn J; Lim JK; Lee HM; Lok AS; Nguyen M; Pan CQ; Mannalithara A; Te H; Reddy KR; Trinh H; Chu D; Tran T; Lau D; Leduc TS; Min A; Trong Le L; Bae H; Van Tran S; Do S; Hann HW; Wong C; Han S; Pillai A; Park JS; Tong M; Scaglione S; Woog J; Kim WR
Am J Gastroenterol; 2016 Sep; 111(9):1297-304. PubMed ID: 27325221
[TBL] [Abstract][Full Text] [Related]
40. Improving screening for hepatocellular carcinoma by incorporating data on levels of α-fetoprotein, over time.
Lee E; Edward S; Singal AG; Lavieri MS; Volk M
Clin Gastroenterol Hepatol; 2013 Apr; 11(4):437-40. PubMed ID: 23247324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
